New drug cocktail aims to stop lung cancer return in Early-Stage patients
NCT ID NCT07485920
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether combining two drugs, tislelizumab and nintedanib, can help control limited-stage small cell lung cancer after standard chemoradiation. About 20 adults with good performance status will receive this consolidation therapy. The goal is to delay cancer progression and improve survival, while monitoring side effects like lung inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Qingdao Central Hospital Affiliated to Rehabilitation University
Qingdao, Shandong, China
Contact Email: •••••@•••••
-
Qingdao Municipal Hospital
Qingdao, Shandong, China
Contact Email: •••••@•••••
-
Weihai Municipal Hospital
Weihai, Shandong, China
Contact Email: •••••@•••••
-
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Contact Email: •••••@•••••
-
Zibo Fourth People's Hospital
Zibo, Shandong, China
Contact Email: •••••@•••••